Additionally, alternative strategies have been proposed, including targeting MCT1 to diminish lactate uptake and inhibiting lactate dehydrogenase A (LDHA) to prevent lactate production, aimed at directly reducing lactate levels and activating T-cell-mediated anti-tumor immunity. The gene discussed is LDHA; the disease is neoplasm.